ReShape Lifesciences Inc. Annual Depreciation in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ReShape Lifesciences Inc. annual/quarterly Depreciation history and growth rate from 2019 to 2024.
  • ReShape Lifesciences Inc. Depreciation for the quarter ending March 31, 2024 was $6K, a 83.8% decline year-over-year.
  • ReShape Lifesciences Inc. annual Depreciation for 2024 was $22K, a 81.8% decline from 2023.
  • ReShape Lifesciences Inc. annual Depreciation for 2023 was $121K, a 63.3% decline from 2022.
  • ReShape Lifesciences Inc. annual Depreciation for 2022 was $330K, a 42.2% increase from 2021.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22K -$99K -81.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-04
2023 $121K -$209K -63.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-04
2022 $330K +$98K +42.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $232K +$217K +1447% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $15K -$385K -96.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 $400K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.